FDA
approval
· 2021-07-26
FDA Approved: TWYNEO — Original Application (Galderma Laboratories, L.P.)
Summary
FDA approved TWYNEO, a fixed-dose combination of tretinoin and benzoyl peroxide, for acne vulgaris under Galderma Laboratories, L.P.'s original NDA.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
ORIG AP for TWYNEO (TRETINOIN AND BENZOYL PEROXIDE)